Page 1

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

DAILY EQUITY REPORT 15 MAY 2019 TH

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

INDIAN FACE

INDIAN MARKET CLOSE

PREVIOUS

! NIFTY

INDIAN EQUITY BENCHMARK - Benchmark indices closed in the green after falling for nine consecutive sessions. Sensex was up 227 points at 37,318.53, while Nifty closed at 11,222, up 73.80 points. About 1223 shares have advanced,

CLOSE

PREVIOUS

1260 shares have declined, and 132 shares are unchanged.

NIKKEI

Sun Pharma, Bharti Airtel, Indiabulls Housing and Vedanta were among top index gainers, while TCS, Tech Mahindra, 2081.84

HCL Technologies and Bajaj Finance were among the top

2079.01

losers on the index. Except IT that fell over 1 percent, all

SECTORIAL INDICES CLOSE

sectoral indices were trading in the green. PSU Bank is the

CHANGE (%)

biggest gainer, surging about 3 percent. Nifty Midcap 100

0.61

CNX 100 S&P CNX 500

CNX 200

was up 80 points at 16737.25, while Nifty Smallcap 100 was

9212.35

0.57

at 6,142.80, up 43 points.

4622.05

0.72

GLOBAL FACE

5806.90

0.59 0.59

BANK NIFTY

!

TOP GAINERS

Asian Market - Asian markets finished broadly lower today with shares in Hong Kong leading the region. The Hang Seng is down 1.50% while China's Shanghai Composite is off 0.69% and Japan's Nikkei 225 is lower by 0.59%.

CLOSE

6.49

!

BHARTIARTL

6.07

SUNPHARMA

5.63

U.S. Market – North and South American markets finished broadly lower on Monday with shares in Brazil leading the region. The Bovespa is down 2.69% while U.S.'s S&P 500 is off

4.64

2.41% and Mexico's IPC is lower by 0.55%.

!

TOP LOSERS CLOSE

CHANGE (%)

TECHM

European markets – European markets are broadly higher today with shares in France leading the region. The CAC 40 is

up 1.07% while London's FTSE 100 is up 0.84% and Germany's DAX is up 0.46%.

BAJFINANCE

2,885.75

-1.57

2,095.80

-1.55

1,067.15

-1.52

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

NIFTY SPOT

MARKET MOVERS UPSIDE SCRIPT

CLOSE

GAIL

TREND

(%) 6.49 3.82 2.97

S3

10835

STRATEGY

S2

11021

11121

PIVOT POINTS R1

R2

11208

11394

11308

S1-11100 S2-11010

2.84

R3

11581

R1-11355 R2-11470

MARKET MOVERS DOWNSIDE CLOSE

(%) -3.08

INFY

-0.85

ASIANPAINT

-0.56

M&M

-0.49

NET BUY (CR.)

NET SELL (CR)

STRATEGY SELL ON RISE

2972.22 S1 3847.54

DII

27966

28464

28727

PIVOT POINTS P R1

28962

29225

R2

R3

29460

29958

RESISTANCE

NSE TOTALS

BANK NIFTY

ADVANCE S NIFTY BANK NIFTY

3

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

MARKET TALKS

!

!

Siemens PAT up 27.6% yoy at Rs280cr in Q2FY19

!

Karnataka Banks Q4FY19 PAT at Rs477.24cr

Siemens recorded a Profit after Tax (PAT) for the second

Karnataka Bank posted an all-time high annual net profit

quarter of Financial Year 2019 at Rs280cr, which is

of Rs477.24cr for the FY19, with a growth rate of

increased by 27.6% over the same period last year.

46.57%. The previous highest net profit of Rs452.26cr

Revenue stood at Rs3, 461cr, a 9.4% increase over the

was posted during the year 2016-17. The Non-

corresponding quarter of the previous year, the company

Performing Assets (NPA) also moderated. The GNPA

said in the filing to the exchanges on Tuesday. The

[Gross Non-Performing Assets] of the Bank declined to

companys new orders for the quarter stood at Rs3, 635cr,

4.41% as of March 31, 2019, from 4.92% as on March 31,

a 24.3% increase over the second quarter of Financial Year

2018. Similarly, the NNPA (Net Non-Performing Assets)

2018. Order backlog recorded a six-year high.

also moderated to 2.95% from 2.96% as on March 31,

Lupin receives EIR for Pharma co vigilance inspection

2018.

Lupin in its filing to the exchanges on Tuesday informed that the company has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for the Post-Marketing Adverse Drug Experience (PADE) inspection, indicating successful closure of the inspection. The inspection was conducted at Lupin's global pharmacovigilance group DSRM (Drug Safety & Risk Management) based out of Mumbai between January 14, 2019, and January 18, 2019,

!

the company said in a press note today.

Glenmark gets USFDA nod for Esomeprazole Magnesium DR capsules Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Esomeprazole Magnesium DelayedRelease Capsules USP, 20 mg and 40 mg, a generic version of Nexium Delayed-Release Capsules, 20 mg and 40 mg, of AstraZeneca Pharmaceuticals LP. According to IQVIA sales data for the 12-month period ending March 2019, the Nexium Delayed-Release Capsules, 20 mg and 40 mg market2 achieved annual sales of approximately $395.1 million. Glenmarks current portfolio consists of 153 products authorized for distribution in the U.S. marketplace and 58 ANDAs pending approval with the USFDA.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

NAME OF THE STOCK

: SRF

DATE

: 15/05/2019

SEGMENT

: CASH

CHART TYPE

: Candlestick

EXCHANGE

: NSE

TECHNICAL INDICATORS USED

: VOLUME.MACD,RSI.

CHART

INVESTMENT ADVICE: CALL CS CALL:- BUY SRF IN CASH ABOVE 2600 TGT 2660 SL 2550

RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk.

Capitalstars Financial Research Private Ltd., Reserves all Rights.

INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:Intraday stock tips Financial advisory company Share market company Stock Tips

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME

NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE

Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727

Report Is Checked by Investment Advisor:

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

Profile for CapitalStars

Daily Equity Report 15 May 2019  

Capitalstars, financial research private limited is a SEBI Registered, provide Stock Tips,Share Market Tips , commodity & currency tips....

Daily Equity Report 15 May 2019  

Capitalstars, financial research private limited is a SEBI Registered, provide Stock Tips,Share Market Tips , commodity & currency tips....

Advertisement